Florida / New York

Ph: 561.316.3330

A Publication for the Practicing Medical Specialist, Industry Executive & Investor

Carestream Continues Drive to Improve Image Quality and Workflow With 45 Patents in 2021

“Carestream continuously strives to deliver cutting-edge technologies worldwide, and these patents demonstrate our commitment to meet the evolving needs of providers and patients alike,” said Eugene Shkurko, Intellectual Property Counsel at Carestream.

Carestream Health was awarded 45 new patents in 2021 for global advances in artificial intelligence (AI), digital radiography (DR) workflow and detectors as well as other healthcare imaging technology areas.

Twenty-three of the patents were awarded by the U.S. Patent and Trademark Office, while an additional 22 patents were received in European and Asian countries.

“Carestream continuously strives to deliver cutting-edge technologies worldwide, and these patents demonstrate our commitment to meet the evolving needs of providers and patients alike,” said Eugene Shkurko, Intellectual Property Counsel at Carestream. “Our research and development teams are always focused on enabling better diagnoses and enriching patient care with critical innovations such as lowering radiation dose without sacrificing our standards in image quality, and optimizing provider workflow with AI.”

Patents earned by Carestream’s scientists and engineers in 2021 include:

  • New medical image capture technologies with AI that help remove undesired bony structures from X-ray images to increase image clarity
  • Technology advances in image capture that automate positioning of the X-ray source according to the exam entered by the radiographer; and
  • A patent for X-ray detectors with stepped edges that fit together so that the combined detectors can be used for long-length imaging.

Carestream’s growing product portfolio includes 2D and 3D digital medical imaging technology for general radiology and specialty areas such as pediatrics and fluoroscopic surgical imaging, along with digital laser imagers that output medical images to film. These technologies fit budget, workflow, safety and space requirements of imaging facilities worldwide.

More Posts

Merck KGaA, Darmstadt, Germany Completes Acquisition of SpringWorks Therapeutics to Accelerate Sustainable Growth of its Healthcare Business

SpringWorks immediately adds revenue and accelerates mid- to long-term growth for Merck KGaA, Darmstadt, Germany’s Healthcare business sector. Acquisition marks the formation of a rare tumor business for Merck KGaA, Darmstadt, Germany including SpringWorks’ portfolio and pimicotinib. SpringWorks’ rare tumor portfolio includes Ogsiveo, a first-in-disease systemic therapy for adults with desmoid tumors and Gomekli a first and only approved therapy for adults and children with NF1-PN.